Information  X 
Enter a valid email address

Healthperm Rsrc Ltd (HPR)

  Print      Mail a friend

Tuesday 02 October, 2018

Healthperm Rsrc Ltd

Director Shareholding, Loan Notes and Directorate

RNS Number : 7387C
Healthperm Resourcing Ltd
02 October 2018
 

HEALTHPERM RESOURCING LTD

("Healthperm" or the "Company")

 

director/PDMR shareholding, loan notes and directorate changes

 

 

Director/PDMR Shareholding

On 2 October 2018 the Company was notified by David Sumner, Non-Executive Co-Chairman of the Company that, as part of a corporate restructuring and consolidation exercise, he has sold all of the ordinary shares of no par value in the Company ("Ordinary Shares") that were previously legally and beneficially held in his personal name to Gulf Healthcare Holdings Limited ("GHHL").  He has also sold his entire interest in GHHL to Sumner Group Holdings Limited ("SGHL"), a company incorporated in Jersey.  David Sumner is the controlling majority shareholder of SGHL.

 

Loan Notes

With reference to the Loan Note Instrument issued by Healthperm Resourcing (UK) Limited, a subsidiary of the Company, dated 10 September 2015 as amended by the Deed of Variation dated 5 March 2018 and the Subscription Letter dated 5 March 2018 ("Loan Notes"), the Company hereby confirms that on 2 October 2018 the Company was notified that David Sumner had transferred all of the Loan Notes registered in his name to GHHL and that any outstanding commitment to subscribe for the Loan Notes shall be met by GHHL.  In connection with the aforementioned corporate restructuring and consolidation exercise, GHHL's commitment to subscribe for Loan Notes will be guaranteed by SGHL.

 

Directorate Changes

As part of the aforementioned corporate restructuring and consolidation exercise, and to focus his efforts on the future development of the SGHL portfolio, David Sumner has resigned from the Board of the Company.  The Company would like to thank David for his considerable support and constructive input to Healthperm and in helping us set a clear roadmap for future growth.  Alan Kitchin has become Non-Executive Chairman of the Company with immediate effect.

 

 

The information below, set out in accordance with the requirements of the EU Market Abuse

Regulation, provides further details:

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

David Sumner

2

Reason for the notification

a)

Position/status

Non-Executive Co-Chairman, Healthperm Resourcing Limited

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Healthperm Resourcing Limited

b)

LEI

213800MZ8TMFB1U3N732

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of no par value

 

 


SG9999015259

b)

Nature of the transactions

Sale of Ordinary Shares by David Sumner

Purchase of Ordinary Shares by Gulf Healthcare Holdings Limited

c)

Price(s) and volume(s)


Price(s)

Volume(s)


Nil

4,240,486


d)

Aggregated information

-     - Aggregated volume

-     - Price

 

4,240,486

£ Nil

e)

Date of the transaction

2 October 2018

f)

Place of the transaction

Off-market

 

 

 

Enquiries:

Healthperm Resourcing Ltd.


Steve Howson, Chief Executive Officer

Tel: +44 (0) 7815 927 943

WH Ireland Ltd (Corporate Adviser)


Tim Feather / James Sinclair-Ford

Tel: +44 (0)113 394 6600

Daniel Stewart & Company PLC (Broker)


David Lawman

Tel: +44 (0)20 7776 6550

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected]com or visit www.rns.com.
 
END
 
 
NEXEALEAEFEPFFF

a d v e r t i s e m e n t